FGF23 and hypophosphatemia: In the case of PMT, the resulting hypophosphatemia is due to high levels of fibroblast growth factor-23 (FGF23), a hormone that blocks the synthesis of 1,25-dihydroxycholecalciferol by inhibiting 1-α-hydroxylase and increasing renal phosphate excretion [7].